Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,345,000
Closed -$256M 108
2021
Q4
$256M Buy
3,345,000
+895,000
+37% +$71.3M 4.25% 3
2021
Q3
$184M Buy
+2,450,000
New +$186M 3.07% 8
2020
Q4
Sell
-52,400
Closed -$4.15M 146
2020
Q3
$4.15M Buy
+52,400
New +$4.1M 0.11% 72
2019
Q2
Sell
-209,600
Closed -$16.6M 139
2019
Q1
$16.6M Buy
+209,600
New +$15.7M 0.33% 45

Other funds holding MRK

PointState Capital's MRK Position: Q3 2022 in Review

PointState Capital sold out of Merck (MRK) in Q3 2022, closing a stake of 55,826 shares — an estimated $5.09M sold.

PointState Capital first reported a position in MRK in Q3 2016 and held it in 11 quarters. The position peaked at $173M in Q3 2016. 2,990 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • PointState Capital reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
  • PointState Capital sold 55,826 Merck shares in Q3 2022, an estimated $5.09M.
  • PointState Capital first reported a position in Merck in Q3 2016 and held it in 11 quarters.
  • PointState Capital's Merck position peaked at $173M in Q3 2016.
  • 2,990 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on PointState Capital's 13F filing for Q3 2022, filed 10 Nov 2022.